-+ 0.00%
-+ 0.00%
-+ 0.00%

GH Research Appoints Vanina Popova as Chief Development Officer

PUBT·11/13/2026 12:57:11
GH Research Appoints Vanina Popova as Chief Development Officer
  • GH Research appointed Vanina Popova as chief development officer.
  • Popova will lead GH001 clinical development into pivotal programs for treatment-resistant depression and postpartum depression.
  • She joins from Johnson & Johnson following more than 20 years in neuroscience, including leading the pivotal TRANSFORM-2 trial for Spravato.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GH Research plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130755PRIMZONEFULLFEED9877164) on November 13, 2026, and is solely responsible for the information contained therein.